Pioneering Real-Time Bioprocess Monitoring Solutions

With a foundation built on more than 40 years of biosensor research at Linköping University, ArgusEye was founded in 2017 as a university spin-off. The founding team, consisting of Erik Martinsson, Daniel Aili, Ingemar Lundström and Carl-Fredrik Mandenius, among others, set out to develop advanced sensing solutions for the biopharmaceutical industry, using a technology based on Localized Surface Plasmon Resonance (LSPR). 

Starting out small, the early years focused on developing a strong technical foundation for productionfication of the technology supported. This groundwork paved the way for two successful investment rounds in 2021 and 2024, providing the resources to first capture our first customers and later accelerate growth and product development. 

The year 2024 marked a new phase for ArgusEye. We moved into larger facilities in Ebbepark, Linköping, in January and we launched our first product, AugaOne™, in March. That same year, ArgusEye was named by Ny Teknik as one of Sweden’s most promising young tech companies for the third consecutive year, following recognition in 2022 and 2023. 

Today, a growing team of specialists in biosensors, biochemistry, hardware and software is driving the development of the next generation of sensor technology.